ACETYLCYSTEINE SANDOZ EFFERVESCENT TABLETS 600MG

Land: Singapore

Sprog: engelsk

Kilde: HSA (Health Sciences Authority)

Køb det nu

Hent Indlægsseddel (PIL)
26-01-2024
Hent Produktets egenskaber (SPC)
06-06-2024

Aktiv bestanddel:

Acetylcysteine

Tilgængelig fra:

SANDOZ SINGAPORE PTE. LTD.

ATC-kode:

R05CB01

Dosering:

600mg

Lægemiddelform:

TABLET, EFFERVESCENT

Sammensætning:

Acetylcysteine 600mg

Indgivelsesvej:

ORAL

Recept type:

General Sale List

Fremstillet af:

Hermes Pharma GmbH

Autorisation status:

ACTIVE

Autorisation dato:

2014-07-30

Indlægsseddel

                                1
PACKAGE LEAFLET: INFORMATION FOR THE USER
ACETYLCYSTEINE SANDOZ EFFERVESCENT TABLETS 600 MG
Active substance: acetylcysteine
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU. THIS MEDICINE IS
AVAILABLE WITHOUT PRESCRIPTION. HOWEVER, YOU STILL NEED TO USE
ACETYLCYSTEINE SANDOZ
CAREFULLY TO GET THE BEST RESULTS FROM IT.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
You must contact a doctor if your symptoms worsen or do not improve.
-
If any of the side effects gets serious, or if you notice any side
effect not listed in this leaflet, please
tell your doctor or pharmacist.
IN THIS LEAFLET
1.
What ACETYLCYSTEINE SANDOZ is and what it is used for
2.
Before you take ACETYLCYSTEINE SANDOZ
3.
How to take ACETYLCYSTEINE SANDOZ
4.
Possible side effects
5.
How to store ACETYLCYSTEINE SANDOZ
6.
Further information
1.
WHAT ACETYLCYSTEINE SANDOZ IS AND WHAT IT IS USED FOR
ACETYLCYSTEINE SANDOZ is a medicine to liquefy viscous mucus in the
airways.
ACETYLCYSTEINE SANDOZ IS USED
to loosen mucus and to facilitate expectoration in cases of
respiratory diseases with viscous mucus.
2.
BEFORE YOU TAKE ACETYLCYSTEINE SANDOZ
DO NOT TAKE ACETYLCYSTEINE SANDOZ
-
if you are hypersensitive (allergic) to acetylcysteine or to any of
the ingredients of
ACETYLCYSTEINE SANDOZ
.
TAKE SPECIAL CARE WITH ACETYLCYSTEINE SANDOZ
Mucolytic agents can induce respiratory obstruction in children under
2 years of age. Due to the
physiological characteristics of the airways in this age group, the
ability to expectorate may be limited.
Therefore, mucolytic agents should not be used in children under 2
years of age.
Caution should be taken in patients suffering from or with a history
of peptic ulcer.
Patients suffering from bronchial asthma must be strictly controlled
during the therapy; if difficulty in
breathing (bronchospasm) occurs, the treatment must immediately be
suspended.
TAKING OTHER MEDICINES
Tell your doctor or pharmacist if you are t
                                
                                Læs hele dokumentet
                                
                            

Produktets egenskaber

                                _VON SEESTALLER , 15:10, 07.02.2018_
Schwass Peggy
Digitally signed by Schwass Peggy
DN: dc=com, dc=novartis, ou=people, ou=TO, serialNumber=827303,
cn=Schwass Peggy
Reason: technical approved by Hermes DE / Salutas Mat.no correct
Date: 2018.02.07 16:39:01 +01'00'
Lim Sue May
Digitally signed by Lim Sue May
DN: dc=com, dc=novartis, ou=people, ou=GX, serialNumber=1964248,
cn=Lim Sue May
Reason: I am approving this document
Date: 2018.02.08 09:39:44 +08'00'
Wong Huey Ping
Digitally signed by Wong Huey Ping
DN: dc=com, dc=novartis, ou=external-gold, serialNumber=1850053,
cn=Wong Huey Ping
Reason: I am approving this document
Date: 2018.02.08 15:18:39 +08'00'
                                
                                Læs hele dokumentet
                                
                            

Søg underretninger relateret til dette produkt